|[May 08, 2014]
Research and Markets: Medullary Thyroid Cancer - Pipeline Review, H1 2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/krs84x/medullary_thyroid)
has announced the addition of the "Medullary
Thyroid Cancer - Pipeline Review, H1 2014" report to their
This report provides comprehensive information on the therapeutic
development for Medullary Thyroid Cancer, complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Medullary Thyroid Cancer and special features on late-stage and
The report enhances decision making capabilities and help to create
effective counter srategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
The report provides a snapshot of the global therapeutic landscape of
Medullary Thyroid Cancer
The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
The report reviews key players involved in the therapeutics
development for Medullary Thyroid Cancer and enlists all their major
and minor projects
The report summarizes all the dormant and discontinued pipeline
A review of the Medullary Thyroid Cancer products under development by
companies and universities/research institutes based on information
derived from company and industry-specific sources
Pipeline products coverage based on various stages of development
ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline
Coverage of the Medullary Thyroid Cancer pipeline on the basis of
target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products
Ariad Pharmaceuticals, Inc.
Nerviano Medical Sciences S.r.l.
Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd.
For more information visit http://www.researchandmarkets.com/research/krs84x/medullary_thyroid
[ Back To TMCnet.com's Homepage ]